BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37075069)

  • 1. Exosomes: Recent Advances and Challenges as Targeted Therapeutic Delivery Vesicles.
    Jadhav S; Kumar A; Gulbake A
    Crit Rev Ther Drug Carrier Syst; 2023; 40(4):101-133. PubMed ID: 37075069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards Microfluidic-Based Exosome Isolation and Detection for Tumor Therapy.
    Wang J; Ma P; Kim DH; Liu BF; Demirci U
    Nano Today; 2021 Apr; 37():. PubMed ID: 33777166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.
    Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L
    Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of Extracellular Vesicles by a Microfluidic Platform to Diagnose and Monitor Pancreatic Cancer.
    Sancho-Albero M; Sebastián V
    Methods Mol Biol; 2023; 2679():181-191. PubMed ID: 37300616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-Based Drug Delivery: Translation from Bench to Clinic.
    Koh HB; Kim HJ; Kang SW; Yoo TH
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives.
    Butreddy A; Kommineni N; Dudhipala N
    Nanomaterials (Basel); 2021 Jun; 11(6):. PubMed ID: 34204903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine.
    Contreras-Naranjo JC; Wu HJ; Ugaz VM
    Lab Chip; 2017 Oct; 17(21):3558-3577. PubMed ID: 28832692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications.
    Amiri A; Bagherifar R; Ansari Dezfouli E; Kiaie SH; Jafari R; Ramezani R
    J Transl Med; 2022 Mar; 20(1):125. PubMed ID: 35287692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Microfluidic Device for Exosome Isolation in Point-of-Care Settings.
    Ramnauth N; Neubarth E; Makler-Disatham A; Sher M; Soini S; Merk V; Asghar W
    Sensors (Basel); 2023 Oct; 23(19):. PubMed ID: 37837121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biogenesis, Isolation, and Detection of Exosomes and Their Potential in Therapeutics and Diagnostics.
    Sonbhadra S; Mehak ; Pandey LM
    Biosensors (Basel); 2023 Aug; 13(8):. PubMed ID: 37622888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and future scope of exosomes in the treatment of cardiovascular diseases.
    Ranjan P; Colin K; Dutta RK; Verma SK
    J Physiol; 2023 Nov; 601(22):4873-4893. PubMed ID: 36398654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of engineered exosomes from the preparation strategy to therapeutic applications.
    Fan X; Zhang Y; Liu W; Shao M; Gong Y; Wang T; Xue S; Nian R
    Biomater Sci; 2024 Jun; ():. PubMed ID: 38828621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric Biosensors for Characterizing Extracellular Vesicle Subpopulations.
    Shaabani N; Meira SR; Marcet-Palacios M; Kulka M
    ACS Pharmacol Transl Sci; 2023 Mar; 6(3):387-398. PubMed ID: 36926451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and usage of exosomes in central nervous system diseases.
    Wang W; Sun H; Duan H; Sheng G; Tian N; Liu D; Sun Z
    CNS Neurosci Ther; 2024 Mar; 30(3):e14677. PubMed ID: 38497529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances and challenges in the recovery and purification of cellular exosomes.
    Ayala-Mar S; Donoso-Quezada J; Gallo-Villanueva RC; Perez-Gonzalez VH; González-Valdez J
    Electrophoresis; 2019 Dec; 40(23-24):3036-3049. PubMed ID: 31373715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidics for detection of exosomes and microRNAs in cancer: State of the art.
    Mousavi SM; Amin Mahdian SM; Ebrahimi MS; Taghizadieh M; Vosough M; Sadri Nahand J; Hosseindoost S; Vousooghi N; Javar HA; Larijani B; Hadjighassem MR; Rahimian N; Hamblin MR; Mirzaei H
    Mol Ther Nucleic Acids; 2022 Jun; 28():758-791. PubMed ID: 35664698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment.
    Zhao Y; Tan H; Zhang J; Pan B; Wang N; Chen T; Shi Y; Wang Z
    Int J Nanomedicine; 2023; 18():6847-6868. PubMed ID: 38026523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milk exosomes: Nature's abundant nanoplatform for theranostic applications.
    Adriano B; Cotto NM; Chauhan N; Jaggi M; Chauhan SC; Yallapu MM
    Bioact Mater; 2021 Aug; 6(8):2479-2490. PubMed ID: 33553829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform.
    Xu X; Xu L; Wen C; Xia J; Zhang Y; Liang Y
    Mater Today Bio; 2023 Oct; 22():100760. PubMed ID: 37636982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional and Nonconventional Sources of Exosomes-Isolation Methods and Influence on Their Downstream Biomedical Application.
    Janouskova O; Herma R; Semeradtova A; Poustka D; Liegertova M; Hana Auer M; Maly J
    Front Mol Biosci; 2022; 9():846650. PubMed ID: 35586196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.